Skip to content

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04940000
Enrollment
105
Registered
2021-06-25
Start date
2021-09-02
Completion date
2028-09-30
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ORL Cancer

Keywords

Video-Assisted Speech Therapy

Brief summary

Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.

Interventions

OTHERPatient managed at the IUCT-O and by a private speech therapist (near the patient's home).

Each patient included will have a video-assisted remote speech therapy consultation with a private speech therapist (near the patient's home) and the expert speech therapist of IUCT-O center. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire.

Sponsors

Institut Claudius Regaud
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years at study entry. 2. Patient with carcinological pathology of the VADS, relevant to surgery and/or radiotherapy and/or chemotherapy. 3. Patient managed at the IUCT-O and by a private speech therapist (near the patient's home). 4. Patient affiliated to a Social Security system in France. 5. Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedure.

Exclusion criteria

1. Pregnant or lactating women. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).

Design outcomes

Primary

MeasureTime frame
The rate of patients for whom tele-therapy will be considered successful.12 months for each patient

Secondary

MeasureTime frame
The rate of patients with full or partial resolution of speech-language pathology at the end of the telecare consultation.12 months for each patient

Countries

France

Contacts

Primary ContactJérôme SARINI
sarini.jerome@iuct-oncopole.fr05 31 15 60 16
Backup ContactJean-Claude FARENC
farenc.jean-claude@iuct-oncopole.fr05 31 15 51 97

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026